Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Heydmann

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Virologie (Montrouge, France)|October 28, 2020
[Solute carrier NTCP, a key actor in liver infections by hepatitis viruses and a promising antiviral target]Eloi R Verrier, Laura Heydmann, Thomas F Baumert, et al.
Cellular and Molecular Life Sciences : CMLS|August 12, 2018
The functional role of sodium taurocholate cotransporting polypeptide NTCP in the life cycle of hepatitis B, C and D virusesCarla Eller, Laura Heydmann, Che C Colpitts, et al.
Virologie (Montrouge, France)|September 24, 2022
[Hepatitis C virus and neutralizing antibodies]Catherine Fauvelle, Laura Heydmann, Mirjam B Zeisel, et al.
Hepatology International|July 13, 2017
A cinnamon-derived procyanidin type A compound inhibits hepatitis C virus cell entryCatherine Fauvelle, Melanie Lambotin, Laura Heydmann, et al.
Viruses|December 4, 2012
Neutralizing antibodies and pathogenesis of hepatitis C virus infectionSamira Fafi-Kremer, Catherine Fauvelle, Daniel J Felmlee, et al.
Plos Pathogens|May 17, 2014
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agentsFei Xiao, Isabel Fofana, Laura Heydmann, et al.
Gut|April 1, 2017
Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escapeChe C Colpitts, Rajiv G Tawar, Laurent Mailly, et al.
The Journal of Experimental Medicine|April 23, 2014
IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapiesFrancois H T Duong, Gaia Trincucci, Tujana Boldanova, et al.
Antiviral Research|December 13, 2022
A stable hepatitis D virus-producing cell line for host target and drug discoveryCharlotte Bach, Julie Lucifora, Marion Delphin, et al.
Antiviral Research|January 2, 2019
In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infectionLaurent Mailly, Florian Wrensch, Laura Heydmann, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Virologie (Montrouge, France)|October 28, 2020
[Solute carrier NTCP, a key actor in liver infections by hepatitis viruses and a promising antiviral target]Eloi R Verrier, Laura Heydmann, Thomas F Baumert, et al.
Cellular and Molecular Life Sciences : CMLS|August 12, 2018
The functional role of sodium taurocholate cotransporting polypeptide NTCP in the life cycle of hepatitis B, C and D virusesCarla Eller, Laura Heydmann, Che C Colpitts, et al.
Virologie (Montrouge, France)|September 24, 2022
[Hepatitis C virus and neutralizing antibodies]Catherine Fauvelle, Laura Heydmann, Mirjam B Zeisel, et al.
Hepatology International|July 13, 2017
A cinnamon-derived procyanidin type A compound inhibits hepatitis C virus cell entryCatherine Fauvelle, Melanie Lambotin, Laura Heydmann, et al.
Viruses|December 4, 2012
Neutralizing antibodies and pathogenesis of hepatitis C virus infectionSamira Fafi-Kremer, Catherine Fauvelle, Daniel J Felmlee, et al.
Plos Pathogens|May 17, 2014
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agentsFei Xiao, Isabel Fofana, Laura Heydmann, et al.
Gut|April 1, 2017
Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escapeChe C Colpitts, Rajiv G Tawar, Laurent Mailly, et al.
The Journal of Experimental Medicine|April 23, 2014
IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapiesFrancois H T Duong, Gaia Trincucci, Tujana Boldanova, et al.
Antiviral Research|December 13, 2022
A stable hepatitis D virus-producing cell line for host target and drug discoveryCharlotte Bach, Julie Lucifora, Marion Delphin, et al.
Antiviral Research|January 2, 2019
In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infectionLaurent Mailly, Florian Wrensch, Laura Heydmann, et al.
Pageof 3